Immunogenicity of Yellow Fever Vaccine in a Pediatric Population Vaccinated at 12-23 Months of Age in Argentina
Condition(s):Yellow FeverLast Updated:March 14, 2023Enrolling by invitation
Hide Studies Not Open or Pending
Condition(s):Yellow FeverLast Updated:March 14, 2023Enrolling by invitation
Condition(s):Yellow FeverLast Updated:June 13, 2023Recruiting
Condition(s):Yellow FeverLast Updated:April 18, 2022Not yet recruiting
Condition(s):FeverLast Updated:June 29, 2022Recruiting
Condition(s):Fever; Due to Heat; InfectionLast Updated:August 26, 2021Unknown status
Condition(s):FeverLast Updated:October 4, 2021Completed
Condition(s):Pediatric Oncology Patients With Risk for InfectionsLast Updated:July 11, 2023Not yet recruiting
Condition(s):FeverLast Updated:March 24, 2023Recruiting
Condition(s):Q FeverLast Updated:January 2, 2020Withdrawn
Condition(s):Systemic Lupus; Rheumatoid Arthritis; Spondyloarthritis; Inflammatory Myopathy; Systemic Sclerosis; Mixed Connective Tissue Disease; Takayasu Arteritis; Granulomatosis With Polyangiitis; Sjogren’s Syndrome; Juvenile Idiopathic Arthritis; Juvenile DermatomyositisLast Updated:April 26, 2019Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.